Central myelin gene expression during postnatal development in rats exposed to nicotine gestationally

Neuroscience Letters

Volumn 553, Issue , 2013, Pages 115-120

  Cao, Junran ^a   Dwyer, Jennifer B ^b   Gautier, Nicole M ^a   Leslie, Frances M ^b   Li, Ming D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Development; Gestational; Myelin; Nicotine; Sex; Smoking

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; ASPARTOACYLASE; GAP JUNCTION PROTEIN; GAP JUNCTION PROTEIN GAMMA 3; MYELIN; MYELIN ASSOCIATED OLIGODENDROCYTIC BASIC PROTEIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NICOTINE; PROTEOLIPID PROTEIN; PROTEOLIPID PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; MALE; MENTAL DISEASE; NONHUMAN; NUCLEUS ACCUMBENS; OSMOTIC MINIPUMP; PERINATAL DRUG EXPOSURE; POSTNATAL DEVELOPMENT; PREFRONTAL CORTEX; PREGNANCY; PRIORITY JOURNAL; PROGENY; PUTAMEN; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

DEVELOPMENT; GESTATIONAL; MYELIN; NICOTINE; SEX; SMOKING;

AGE FACTORS; ANIMALS; BRAIN; FEMALE; GENE EXPRESSION; MALE; MATERNAL EXPOSURE; MYELIN SHEATH; NICOTINE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PUTAMEN; RATS, SPRAGUE-DAWLEY;

EID: 84884391998     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.08.012     Document Type: Article

References (47)

1. Arnold A.P. Sex chromosomes and brain gender, Nature reviews. Neuroscience 2004, 5:701-708.
2. Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol. Aging 2004, 25:5-18. (author reply 49-62).
3. Baumann N., Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 2001, 81:871-927.
4. Benes F.M., Turtle M., Khan Y., Farol P. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch. Gen. Psychiatry 1994, 51:477-484.
5. Biederman J., Mick E., Faraone S.V. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am. J. Psychiatry 2000, 157:816-818.
6. Bora E., Yucel M., Fornito A., Pantelis C., Harrison B.J., Cocchi L., Pell G., Lubman D.I. White matter microstructure in opiate addiction. Addict. Biol. 2012, 17:141-148.
7. Cao J., Dwyer J.B., Mangold J.E., Wang J., Wei J., Leslie F.M., Li M.D. Modulation of cell adhesion systems by prenatal nicotine exposure in limbic brain regions of adolescent female rats. Int. J. Neuropsychopharmacol. 2011, 14:157-174.
8. Cao J., Wang J., Dwyer J.B., Gautier N.M., Wang S., Leslie F.M., Li M.D. Gestational nicotine exposure modifies myelin gene expression in the brains of adolescent rats with sex differences. Transl. psychiatry 2013, 3:e247.
9. Cerghet M., Skoff R.P., Swamydas M., Bessert D. Sexual dimorphism in the white matter of rodents. J. Neurol. Sci. 2009, 286:76-80.
10. Clifford A., Lang L., Chen R. Effects of maternal cigarette smoking during pregnancy on cognitive parameters of children and young adults: a literature review. Neurotoxicol. Teratol. 2012, 34:560-570.
11. Cotrina M.L., Nedergaard M. Brain connexins in demyelinating diseases: therapeutic potential of glial targets. Brain Res. 2012, 1487:61-68.
12. de Monasterio-Schrader P., Jahn O., Tenzer S., Wichert S.P., Patzig J., Werner H.B. Systematic approaches to central nervous system myelin. Cell. Mol. Life Sci. 2012, 69:2879-2894.
13. Du Y., Dreyfus C.F. Oligodendrocytes as providers of growth factors. J. Neurosci. Res. 2002, 68:647-654.
14. Feng Y. Convergence and divergence in the etiology of myelin impairment in psychiatric disorders and drug addiction. Neurochem. Res. 2008, 33:1940-1949.
15. Fields R.D. White matter in learning, cognition and psychiatric disorders. Trends Neurosci. 2008, 31:361-370.
16. Franke R.M., Belluzzi J.D., Leslie F.M. Gestational exposure to nicotine and monoamine oxidase inhibitors influences cocaine-induced locomotion in adolescent rats. Psychopharmacology (Berl.) 2007, 195:117-124.
17. Franke R.M., Park M., Belluzzi J.D., Leslie F.M. Prenatal nicotine exposure changes natural and drug-induced reinforcement in adolescent male rats. Eur. J. Neurosci. 2008, 27:2952-2961.
18. Fried P.A., James D.S., Watkinson B. Growth and pubertal milestones during adolescence in offspring prenatally exposed to cigarettes and marihuana. Neurotoxicol. Teratol. 2001, 23:431-436.
19. Griffiths I., Klugmann M., Anderson T., Yool D., Thomson C., Schwab M.H., Schneider A., Zimmermann F., McCulloch M., Nadon N., Nave K.A. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998, 280:1610-1613.
20. Griffiths I.R., Schneider A., Anderson J., Nave K.A. Transgenic and natural mouse models of proteolipid protein (PLP)-related dysmyelination and demyelination. Brain Pathol. 1995, 5:275-281.
21. Gutala R., Wang J., Kadapakkam S., Hwang Y., Ticku M., Li M.D. Microarray analysis of ethanol-treated cortical neurons reveals disruption of genes related to the ubiquitin-proteasome pathway and protein synthesis. Alcohol. Clin. Exp. Res. 2004, 28:1779-1788.
22. Hursh J.B. Conduction velocity and diameter of nerve fiber. Am. J. Physiol. Soc. 1939, 127:131-139.
23. Kafitz K.W., Herth G., Bartsch U., Guttinger H.R., Schachner M. Application of testosterone accelerates oligodendrocyte maturation in brains of zebra finches. Neuroreport 1992, 3:315-318.
24. Knopik V.S. Maternal smoking during pregnancy and child outcomes: real or spurious effect?. Dev. Neuropsychol. 2009, 34:1-36.
25. Kolb B., Mychasiuk R., Muhammad A., Li Y., Frost D.O., Gibb R. Experience and the developing prefrontal cortex. Proc. Natl. Acad. Sci. U.S.A. 2012, 109(Suppl. 2):17186-17193.
26. Lappe-Siefke C., Goebbels S., Gravel M., Nicksch E., Lee J., Braun P.E., Griffiths I.R., Nave K.A. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 2003, 33:366-374.
27. Li M.D., Kane J.K., Wang J., Ma J.Z. Time-dependent changes in transcriptional profiles within five rat brain regions in response to nicotine treatment, Brain research. Mol. Brain Res. 2004, 132:168-180.
28. Martini R., Mohajeri M.H., Kasper S., Giese K.P., Schachner M. Mice doubly deficient in the genes for P0 and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin. J. Neurosci. 1995, 15:4488-4495.
29. Matta S.G., Elberger A.J. Combined exposure to nicotine and ethanol throughout full gestation results in enhanced acquisition of nicotine self-administration in young adult rat offspring. Psychopharmacology (Berl.) 2007, 193:199-213.
30. Mayer M.C., Meinl E. Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more. Ther. Adv. Neurol. Disord. 2012, 5:147-159.
31. McTigue D.M., Tripathi R.B. The life, death, and replacement of oligodendrocytes in the adult CNS. J. Neurochem. 2008, 107:1-19.
32. Meyer D.C., Carr L.A. The effects of perinatal exposure to nicotine on plasma LH levels in prepubertal rats. Neurotoxicol. Teratol. 1987, 9:95-98.
33. Montague P., McCallion A.S., Davies R.W., Griffiths I.R. Myelin-associated oligodendrocytic basic protein: a family of abundant CNS myelin proteins in search of a function. Dev. Neurosci. 2006, 28:479-487.
34. Nave K.A., Trapp B.D. Axon-glial signaling and the glial support of axon function. Annu. Rev. Neurosci. 2008, 31:535-561.
35. Park M.K., Loughlin S.E., Leslie F.M. Gestational nicotine-induced changes in adolescent neuronal activity. Brain Res. 2006, 1094:119-126.
36. Paus T., Keshavan M., Giedd J.N. Why do many psychiatric disorders emerge during adolescence?. Nat. Rev. Neurosci. 2008, 9:947-957.
37. Paxinos G., Watson C. The Rat Brain in Stereotxic Coordinates 2005, Academic Press Inc., San Diego.
38. Peterson B.S. Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome. J. Clin. Psychiatry 1996, 57(Suppl. 9):24-34.
39. Roy K., Murtie J.C., El-Khodor B.F., Edgar N., Sardi S.P., Hooks B.M., Benoit-Marand M., Chen C., Moore H., O'Donnell P., Brunner D., Corfas G. Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:8131-8136.
40. Schaeren-Wiemers N., Bonnet A., Erb M., Erne B., Bartsch U., Kern F., Mantei N., Sherman D., Suter U. The raft-associated protein MAL is required for maintenance of proper axon - glia interactions in the central nervous system. J. Cell Biol. 2004, 166:731-742.
41. Sokolov B.P. Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies?. Int. J. Neuropsychopharmacol. 2007, 10:547-555.
42. Sowell E.R., Thompson P.M., Holmes C.J., Jernigan T.L., Toga A.W. In vivo evidence for post-adolescent brain maturation in frontal and striatal regions. Nat. Neurosci. 1999, 2:859-861.
43. Stocker S., Guttinger H.R., Herth G. Exogenous testosterone differentially affects myelination and neurone soma sizes in the brain of canaries. Neuroreport 1994, 5:1449-1452.
44. Wang J., Leone P., Wu G., Francis J.S., Li H., Jain M.R., Serikawa T., Ledeen R.W. Myelin lipid abnormalities in the aspartoacylase-deficient tremor rat. Neurochem. Res. 2009, 34:138-148.
45. Wei J., Wang J., Dwyer J.B., Mangold J., Cao J., Leslie F.M., Li M.D. Gestational nicotine treatment modulates cell death/survival-related pathways in the brains of adolescent female rats. Int. J. Neuropsychopharmacol. 2011, 14:91-106.
46. Wilkins A., Majed H., Layfield R., Compston A., Chandran S. Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J. Neurosci. 2003, 23:4967-4974.
47. Winer J., Jung C.K., Shackel I., Williams P.M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 1999, 270:41-49.